Clinical Trial Update: D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating D-BACE in combination with chemotherapy and Carelizumab for resectable II-IIIA or potentially resectable T3-4N2 stage IIIB non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Carelizumab
• D-BACE

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: NSCLC (Non-small Cell Lung Cancer) | Phase 3 | Status: RECRUITING